News & Updates

In-ear wearable accurately measures heart rate

15 Sep 2022 by

Under realistic clinical scenarios, an in-ear wearable photoplethysmography (PPG) device can match electrocardiography (ECG) for the measurement of heart rate, according to a recent study.

In-ear wearable accurately measures heart rate

15 Sep 2022

High tea intake helps prolong life

14 Sep 2022

Drinking two or more cups of tea per day appears to lower the risk of mortality, regardless of genetic variation in caffeine metabolism, results of a prospective cohort study have shown.

High tea intake helps prolong life

14 Sep 2022

Early rhythm control reduces CV complications in low-risk AF patients

14 Sep 2022

Use of early rhythm control therapy for atrial fibrillation (AF) in preventing adverse cardiovascular (CV) outcomes also benefits patients with low stroke risk in routine clinical practice, suggests a recent study.

Early rhythm control reduces CV complications in low-risk AF patients

14 Sep 2022

Phase II data reveal treatment potential of pegozafermin for severe hypertriglyceridaemia

14 Sep 2022 by

The phase II ENTRIGUE trial presented at ESC 2022 showed the potential of pegozafermin to improve triglyceride levels and other lipid-related metrics in individuals with severe hypertriglyceridaemia.

Phase II data reveal treatment potential of pegozafermin for severe hypertriglyceridaemia

14 Sep 2022

Nicorandil improves PCI outcomes in STEMI patients

14 Sep 2022

In patients with ST‐segment–elevation myocardial infarction (STEMI), treatment with nicorandil prior to undergoing primary percutaneous coronary intervention (PCI) may result in improved myocardial perfusion grade, increased left ventricular ejection fraction, and reduced myocardial infarct size, according to data from the CHANGE* study.

Nicorandil improves PCI outcomes in STEMI patients

14 Sep 2022

Habitual moderate–heavy drinking ups AF risk even in young Asians

13 Sep 2022 by

At moderate-to-heavy levels, drinking confers increased atrial fibrillation (AF) risk even in young people, as shown in a large Korean cohort study.

Habitual moderate–heavy drinking ups AF risk even in young Asians

13 Sep 2022

Asundexian + DAPT a treatment alternative for acute MI?

13 Sep 2022 by

Adding the oral factor XIa (FXIa) inhibitor asundexian to dual antiplatelet therapy (DAPT) may be a safe and effective oral anticoagulation (OAC) alternative for acute MI patients, findings from the PACIFIC-AMI study suggest.

Asundexian + DAPT a treatment alternative for acute MI?

13 Sep 2022

Polypill strategy triumphs in reducing MACE post-MI

12 Sep 2022 by

A polypill comprising aspirin, ramipril, and atorvastatin, significantly reduced the incidence of major adverse cardiovascular (CV) events in patents with a recent myocardial infarction (MI), according to results of a phase III trial presented at ESC 2022.

Polypill strategy triumphs in reducing MACE post-MI

12 Sep 2022

BP response to standing predicts masked hypertension

12 Sep 2022

Young and middle-aged individuals with hyperreactivity to standing may have masked hypertension, according to a study.

BP response to standing predicts masked hypertension

12 Sep 2022

Icosapent ethyl reduces MI events in statin-treated patients

12 Sep 2022 by

In the REDUCE-IT STEMI trial, icosapent ethyl (IPE) reduced MI events overall and across an array of MI subtypes in statin-treated patients at increased cardiovascular (CV) risk.

Icosapent ethyl reduces MI events in statin-treated patients

12 Sep 2022

News & Updates

Filter by Specialty:

Specialty:

In-ear wearable accurately measures heart rate

In-ear wearable accurately measures heart rate

High tea intake helps prolong life

High tea intake helps prolong life

Early rhythm control reduces CV complications in low-risk AF patients

Early rhythm control reduces CV complications in low-risk AF patients

Phase II data reveal treatment potential of pegozafermin for severe hypertriglyceridaemia

Phase II data reveal treatment potential of pegozafermin for severe hypertriglyceridaemia

Nicorandil improves PCI outcomes in STEMI patients

Nicorandil improves PCI outcomes in STEMI patients

Habitual moderate–heavy drinking ups AF risk even in young Asians

Habitual moderate–heavy drinking ups AF risk even in young Asians

Asundexian + DAPT a treatment alternative for acute MI?

Asundexian + DAPT a treatment alternative for acute MI?

Polypill strategy triumphs in reducing MACE post-MI

Polypill strategy triumphs in reducing MACE post-MI

BP response to standing predicts masked hypertension

BP response to standing predicts masked hypertension

Icosapent ethyl reduces MI events in statin-treated patients

Icosapent ethyl reduces MI events in statin-treated patients